Search Results for "Aricept"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Aricept. Results 1 to 3 of 3 total matches.
See also: donepezil
A Donepezil Patch (Adlarity) for Alzheimer's Disease (online only)
The Medical Letter on Drugs and Therapeutics • Aug 08, 2022 (Issue 1656)
in oral formulations (Aricept, and
generics) for treatment of AD dementia.1
Pronunciation Key
Adlarity ...
A once-weekly transdermal formulation of the
acetylcholinesterase inhibitor donepezil (Adlarity –
Corium) has been approved by the FDA for
treatment of mild, moderate, and severe Alzheimer's
disease (AD) dementia. Donepezil is the second
acetylcholinesterase inhibitor to become available in
a transdermal formulation; transdermal rivastigmine
(Exelon Patch), which is applied once daily, has been
available for years for the same indication. Donepezil
is also available in oral formulations (Aricept, and
generics) for treatment of AD dementia.
Comparison Table: Drugs for Alzheimer's Disease Dementia (online only)
The Medical Letter on Drugs and Therapeutics • Mar 30, 2026 (Issue 1751)
Interactions Comments
Acetylcholinesterase Inhibitors
Donepezil – generic
Aricept (Eisai)
5, 10, 23 mg tabs ...
View the Comparison Table: Drugs for Alzheimer's Disease Dementia
Med Lett Drugs Ther. 2026 Mar 30;68(1751):e57-8 doi:10.58347/tml.2026.1751c | Show Introduction Hide Introduction
Drugs for Dementia
The Medical Letter on Drugs and Therapeutics • Mar 30, 2026 (Issue 1751)
.
DONEPEZIL — Donepezil (Aricept, and generics), a
reversible inhibitor of acetylcholinesterase ...
Alzheimer's disease (AD) is the most common cause
of dementia, but cognitive decline also occurs in
other neurological conditions, such as Parkinson's
disease, Lewy body dementia, vascular dementia, and
frontotemporal dementia.
Med Lett Drugs Ther. 2026 Mar 30;68(1751):49-56 doi:10.58347/tml.2026.1751a | Show Introduction Hide Introduction